This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
NMDA Receptor Function
and you are
between 21 and 45
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of the study is 1. To establish the feasibility of fMRI studies of the interaction of guanfacine and ketamine. 2. To explore the possibility that guanfacine can ameliorate the negative effects of ketamine on task-related prefrontal activation. 3. To assess the strength of any interaction between guanfacine and ketamine.

Provided treatments

  • Drug: Guanfacine
  • Drug: Placebo
Tris trial is registered with FDA with number: NCT01600885. The sponsor of the trial is Yale University and it is looking for 16 volunteers for the current phase.
Official trial title:
The Effects of Ketamine and Guanfacine on Working Memory in Healthy Subjects